Quantcast
Last updated on April 18, 2014 at 10:16 EDT

Latest Anti-diabetic medication Stories

2014-04-16 23:10:18

The Japanese drug maker that was recently ordered to pay $6 billion to a man who claimed that his bladder cancer diagnosis was caused by Actos, makes several other drugs with the same active ingredient. (PRWEB) April 16, 2014 The diabetes drug Actos has made news headlines this week after a jury decided that its manufacturer, Takeda, was responsible for causing bladder cancer in this case. But Actos is just one of several pioglitazone-containing drugs produced by Takeda and all of them...

2014-04-15 16:27:56

LONDON, April 15, 2014 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Tanzeum(TM) (albiglutide) for injection, for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has been approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Albiglutide, a glucagon-like peptide-1 receptor agonist (GLP-1), is a biological product for the...

2014-04-08 00:22:26

DEERFIELD, Ill., April 8, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. announced that in the case of Terrence Allen, et al. v. Takeda Pharmaceuticals North America, Inc., et al, No. 6:12-cv-00064 the jury found in favor of the plaintiffs and awarded $1.475 million in compensatory damages. The allocation of liability was 75% Takeda and 25% Eli Lilly. The jury also awarded $6 billion in punitive damages from Takeda and $3 billion from co-defendant, Eli Lilly. The trial began...

2014-04-07 16:32:35

New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that Sweden—the country already thought to have the second highest prevalence of type 1 diabetes in the world—could have 2-3 times more adolescents and young adults with type 1 diabetes than previously estimated. The research is by Dr Araz Rawshani, Swedish National Diabetes Register, Gothenburg, Sweden, and colleagues. Current estimates in Sweden are based on the...

2014-04-03 12:30:42

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global and China Insulin Industry Report, 2013-2017 As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 382 million in 2013 at a compound annual growth rate of 7.6%. And insulin as the important diabetes medication has also seen increasing...

2014-04-02 16:30:25

DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/37ktl3/global_and ) has announced the addition of the "Global and Chinese Insulin Industry Report - Forecasts to 2017" [http://www.researchandmarkets.com/research/37ktl3/global_and ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) As the third largest human health disease following neoplastic disease, cardiovascular and...

2014-03-28 23:25:00

Nevada case involves allegations that women developed cancer as a result of Actos medication. National network of attorneys is offering no-cost consultations to consumers seeking compensation over similar claims. San Diego, CA (PRWEB) March 28, 2014 http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html Resource4thePeople today announced its latest update for consumers following litigation involving allegations that the use of Actos to treat diabetes can cause...

2014-03-27 08:34:15

Sub-analyses Investigate the Effects of alogliptin on Cardiovascular Mortality Rates and Hospitalization for Heart Failure in Type 2 Diabetes Patients with Recent Acute Coronary Syndrome WASHINGTON and OSAKA, Japan, March 27, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) will present sub-analyses from the global EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome)...

2014-03-26 08:28:48

DUBLIN, Mar. 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5bf97k/research_report ) has announced the addition of the "Concise Analysis of the Chinese Antidiabetic Drug Market" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) As China's society is further aging and obesity caused by improved living level and unhealthy lifestyle is increasing, the prevention and cure to diabetes become more difficult. The...

2014-03-22 23:02:37

The Firm is currently offering free and confidential Byetta lawsuit evaluations to individuals who may have developed pancreatic cancer, pancreatitis or thyroid cancer after taking the Type 2 diabetes medication. New York, NY (PRWEB) March 22, 2014 A year after the U.S. Food and Drug Administration (FDA) publicly vowed to investigate the safety of a drug now involved in Byetta lawsuit (http://www.byettalawsuit.com/) filings, as well as several other Type 2 diabetes medications, court...